$26.17 +0.15 (0.58%) Supernus Pharmaceuticals Inc - NASDAQ

Sep. 23, 2016 | 04:00 PM
Last Trade: 26.17
Trade Time: Sep 23 04:00 PM Eastern Daylight Time
Change: +0.15 (0.58%)
Prev Close: 26.02
Open: 26.02
Bid: 26.16
Ask: 26.17
  1. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?

    Investors Business Daily | Aug. 2, 2016 | 16:09PM EST
  2. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 12:20PM EST
  3. Benzinga's Top Upgrades

    Benzinga | Feb. 8, 2016 | 08:55AM EST
  4. 16 Stocks Moving In Friday's After-Hours Session

    Benzinga | Dec. 11, 2015 | 17:03PM EST
  5. Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR Label

    Benzinga | Oct. 22, 2015 | 18:39PM EST
  6. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD | Jun. 18, 2015 | 14:34PM EST
  7. Benzinga's Top Upgrades

    Benzinga | Jun. 18, 2015 | 09:10AM EST
  8. Jefferies Upgrades Supernus Pharmaceuticals To Buy

    Benzinga | Jun. 18, 2015 | 07:55AM EST
  9. Benzinga's Top Initiations

    Benzinga | Jun. 12, 2015 | 09:19AM EST
  10. Horizon Pharma Up On Bullish Leerink Initiation

    IBD | May. 22, 2015 | 11:39AM EST
  11. Robert Bruce new Buys

    GuruFocus | Feb. 16, 2015 | 10:44AM EST
  12. Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR

    Benzinga | Dec. 10, 2014 | 07:30AM EST
  13. Supernus Reports Issuance of Fifth US Patent Protecting Trokendi XR(R)

    Benzinga | Nov. 24, 2014 | 07:33AM EST
  14. Third Quarter Was Robert Bruce's Busiest in 2014

    GuruFocus | Nov. 21, 2014 | 17:09PM EST
  15. Earnings Scheduled For November 11, 2014

    Benzinga | Nov. 11, 2014 | 04:56AM EST
Trading Center